1994•PubMedRequires access

[Trans-scleral cyclo-photocoagulation. Results over 6 months].

I Aubry, B Arnaud, Claude Reda, C Blanc-Martin, Pascale Fabbro-Péray, Jean-Jacques Fraimout

Open publisher page 5 citations

Abstract

Transscleral contact cyclophotocoagulation with ND YAG Laser continuous mode permits the induction of a focused ciliary process with a secretory surface decrease. This treatment has been used for the treatment of refractory glaucoma since 1987. We report the treatment by transscleral cyclophotocoagulation of 49 patients with terminal glaucoma. All 49 patients had a measurable visual acuity and an elevated intraocular pressure under maximal medical treatment. None could be operated by trabeculectomy. The origin of the glaucoma was neovascular (26 patients), open angle glaucoma (9 patients) secondary glaucoma (14 patients). 62.2% of the patients had an intraocular pressure < or = 25 mm after 6 months; 8% showed decrease visual acuity. We describe the complications of the treatment and compare the efficacy of treatment depending on the origin of the glaucoma: neovascular or not.

About this research paper

What this paper is about

Transscleral contact cyclophotocoagulation with ND YAG Laser continuous mode permits the induction of a focused ciliary process with a secretory surface decrease. This treatment has been used for the treatment of refractory glaucoma since 1987. We report the treatment by transscleral cyclophotocoagulation of 49 patients with terminal glaucoma. All 49 patients had a measurable visual acuity and an elevated intraocular pressure under maximal medical treatment. None could be operated by trabeculectomy. The origin of the glaucoma was neovascular (26 patients), open angle glaucoma (9 patients) secondary glaucoma (14 patients). 62.2% of the patients had an intraocular pressure < or = 25 mm after 6 months; 8% showed decrease visual acuity. We describe the complications of the treatment and compare the efficacy of treatment depending on the origin of the glaucoma: neovascular or not.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Transscleral contact cyclophotocoagulation with ND YAG Laser continuous mode permits the induction of a focused ciliary process with a secretory surface decrease. This treatment has been used for the treatment of refractory glaucoma since 1987. We report the treatment by transscleral cyclophotocoagulation of 49 patients with terminal glaucoma. All 49 patients had a measurable visual acuity and an elevated intraocular pressure under maximal medical treatment. None could be operated by trabeculectomy. The origin of the glaucoma was neovascular (26 patients), open angle glaucoma (9 patients) secondary glaucoma (14 patients). 62.2% of the patients had an intraocular pressure < or = 25 mm after 6 months; 8% showed decrease visual acuity. We describe the complications of the treatment and compare the efficacy of treatment depending on the origin of the glaucoma: neovascular or not.

Key concepts: Medicine, Glaucoma, Intraocular pressure, Ophthalmology, Trabeculectomy, Ciliary body, Visual acuity, Refractory (planetary science)

Related papers

Back to paper searchBrowse research topicsOriginal source
[Trans-scleral cyclo-photocoagulation. Results over 6 months]. — Research Paper | ScholarLens